Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Pharm Biotechnol. 2010 Nov;11(7):757-63.

Pathway-specific, species, and sub-type counterscreening for better GPCR hits in high throughput screening.

Author information

1
Ligand Pharmaceuticals, 3000 Eastpark Blvd., Cranbury, NJ 08512, USA.

Abstract

G protein-coupled receptors represent one of the largest families of drug targets. Time and cost may be saved if GPCR modulators are assessed in terms of signaling pathway selectivity, species selectivity, and selectivity against closely-related family members early in the drug discovery process, perhaps even at the stage of high-throughput screening. Examples are given of how these kinds of selectivity have been addressed during screening.

PMID:
20809897
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Bentham Science Publishers Ltd.
    Loading ...
    Support Center